Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-05-09

FDA Approved: VALSARTAN AND HYDROCHLOROTHIAZIDE — Supplemental Application (Lupin Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved Lupin Pharmaceuticals' supplemental application to market a generic fixed-dose combination of valsartan and hydrochlorothiazide for hypertensio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Valsartan and Hydrochlorothiazide (Valsartan and Hydrochlorothiazide)

Snippet

SUPPL AP for VALSARTAN AND HYDROCHLOROTHIAZIDE (VALSARTAN AND HYDROCHLOROTHIAZIDE)